Ekso Bionics Holdings Inc. (NASDAQ:EKSO) went down by -13.93% during the previous trading session, and it is maintaining the win ahead of Wednesday’s trading session. The share price of the Medical Instruments & Supplies giant went up by $7.23 to trade ended Wednesday trading at $8.40. This is down from the $8.4 price recorded on Tuesday’s trading session. Its performance from the start of the year has also been positive, with EKSO up by 23.27% year-to-date.
Ekso Bionics Holdings Inc. (EKSO) started the day trading at $7.79 and recorded an intraday high of $8.16. It also recorded an intraday low of $7.09 during Wednesday’s trading session. Ekso Bionics Holdings Inc. is a very active stock that recorded a trading volume that is less than -106.42% of the average daily trading volume on Wednesday. The stock’s trading volume on Wednesday was 1380651, which is less than -106.42 of the total average daily trading volume of 2.85 million.
Ekso Bionics Holdings Inc. (NASDAQ:EKSO) 2020 Performance Impressive
The increase in EKSO’s stock price on Wednesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of EKSO currently stands at $19.95, which is higher than the current trading price of the stock by 63.76%. However, EKSO’s current trading price is -221.33% lower than the 52-week low price of $2.25. In terms of trading volume, Ekso Bionics Holdings Inc. currently experienced healthy participation during the last trading session. 1380651 shares of Ekso Bionics Holdings Inc. were traded on the stock exchange on Wednesday, which is less than -106.42% of the 2.85 million average trading volume of the stock.
The performance of the stock has been positive over the past year. EKSO’s performance over the past one year has seen it plunge by -62.05%, while the stock has gone up by 23.27% in the last six months. The quarterly performance of EKSO currently stands at 161.96%, and it is up by 83.04% in the last month. The only positive figure was from the weekly performance, which currently reads 133.23%. At the time of writing EKSO’s report, the company has a total market cap of $45.69M, making it one of the largest publicly-traded companies in the world.Ekso Bionics Holdings Inc. also has over 67 employees all over the world.
EKSO Insider Activities
For Ekso Bionics Holdings Inc., insiders hold 17.40% of all company shares. The insider transactions over the past six months are up by 121.00%. During that period, insiders bought 311,113 shares in 5 transactions. In that same period, insiders sold 0 of their shares in 0 transactions. After these transactions, insiders at Ekso Bionics Holdings Inc. now hold 727.27k shares, which is over 27.90% of the total company stocks. Institutional investors currently hold a large chunk of the EKSO shares, as they control 12.45% of the company’s total stock.
EKSO Fundamental Analysis
For Ekso Bionics Holdings Inc., the stock’s diluted earnings per share (EPS) stands at -1.58. In the coming year, analysts expect the EPS to be -1.34. The stock’s EPS growth this year is 61.70%, 43.80% in the previous five years. In terms of revenue, Ekso Bionics Holdings Inc.’s quarterly sales (YOY) is shrinking at -0.56, which is lower than the average annual revenue of 43.80% over the past half a decade.
The Return on Investment (ROI) on Ekso Bionics Holdings Inc.’s stock currently stands at -176.00%, and it has a net profit margin of -69.00%. The gross margin of the company is 49.30%.
EKSO Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of EKSO currently stands at 56.10%, while the SMA50 is 80.39%. The biggest one is the SMA200, which is currently reading 24.32% ahead of Wednesday’s trading session. The Relative Strength Index of this stock is 62.07.